Robert Mabry

Therapeutic bispecific antibodies: The selection of stable single-chain fragments to overcome engineering obstacles.

Robert Mabry, Mark Snavely, M. Snavely, 2010, IDrugs : the investigational drugs journal.

Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli

George Georgiou, Robert Mabry, Thomas Van Blarcom, 2007, Nature Biotechnology.

Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis.

George Georgiou, Scott Happe, Andrew Hayhurst, 2003, Journal of immunological methods.

Passive Protection against Anthrax by Using a High-Affinity Antitoxin Antibody Fragment Lacking an Fc Region

George Georgiou, Robert Mabry, G. Georgiou, 2005, Infection and Immunity.